AZD3241
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AZD3241, covering 2008-11-13 to 2017-09-25. Get the full timeline:
Most recent: Clinical Trial Update: AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients [Phase 2]